<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Persistent diarrhea in children in resource-limited settings</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Persistent diarrhea in children in resource-limited settings</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Persistent diarrhea in children in resource-limited settings</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sean R Moore, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">B UK Li, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Persistent diarrhea is generally defined as diarrhea lasting 14 days or longer. In resource-limited settings, it is often associated with a chronic enteropathy, with impaired mucosal healing and diminished digestive and absorptive capacity [<a href="#rid1">1</a>], resulting in malabsorption or maldigestion [<a href="#rid2">2</a>]. Although less common than acute diarrhea in resource-limited settings, these prolonged episodes are important, because of their association with chronic complications, including malnutrition and increased risk of death [<a href="#rid3">3,4</a>].</p><p>The major causes and the prevalence of persistent diarrhea differ between resource-limited and resource-abundant settings, calling for different approaches to diagnosis and management:</p><p class="bulletIndent1"><span class="glyph">●</span>In resource-limited settings, persistent diarrhea usually follows an acute episode and typically is associated with serial enteric infections without sufficient time to recover between episodes. Children are at risk of malnutrition and often have other intercurrent illnesses, such as respiratory infections.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In resource-abundant settings, children are less likely to be exposed to serial enteric infections and ensuing malnutrition. In these populations, chronic diarrhea is more likely to be caused by underlying disease. However, enteric infections (particularly in immunocompromised patients), malnutrition, food allergy, and other dietary factors can play a role in some cases. (See  <a class="medical medical_review" href="/z/d/html/5877.html" rel="external">"Overview of the causes of chronic diarrhea in children in resource-abundant settings"</a>.)</p><p></p><p>The pathophysiology and management of persistent diarrhea in resource-limited settings will be reviewed here. UpToDate topics with related material are:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/117772.html" rel="external">"Management of moderate acute malnutrition in children in resource-limited settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/113959.html" rel="external">"Management of uncomplicated severe acute malnutrition in children in resource-limited settings"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DEFINITIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diarrhea</strong> – Objective definitions of diarrhea are based on stool weight or volume. For example, diarrhea can be defined as a stool volume of more than 10 grams/kg/day in infants and toddlers or more than 200 grams/day in older children [<a href="#rid5">5</a>]. However, because assessment of daily stool weights/volumes is difficult in the outpatient and/or resource-limited setting, changes in the frequency and consistency of stool compared with baseline can also be used as a practical clinical indicator of diarrhea. A change in stool consistency is a more accurate indicator of diarrhea than stool frequency [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/5881.html" rel="external">"Approach to chronic diarrhea in children &gt;6 months in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Persistent diarrhea</strong> – Persistent diarrhea is generally defined as loose or watery stools occurring at least three times a day for 14 days or more. Although the 14-day threshold is used for the definition, there is evidence that diarrhea that lasts 7 to 13 days is also associated with adverse outcomes, including stunting, and identifies children at risk of developing persistent diarrhea in the future [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Some authors make a distinction between persistent diarrhea, which they define as having a sudden onset, and chronic diarrhea, which they define as having a gradual onset usually lasting more than 30 days. However, it is frequently difficult to identify the time of onset of the diarrhea and clearly delineate the two entities. Lack of consensus on symptom-based and duration-based definitions of diarrhea remains a challenge [<a href="#rid7">7,8</a>]. Consequently, for the purposes of this review, we will not differentiate between persistent and chronic diarrhea.</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PREVALENCE AND MORBIDITY</span><span class="headingEndMark"> — </span>In resource-limited settings, persistent diarrhea is a common condition. It is most common in infants and toddlers but can also occur in older children [<a href="#rid6">6</a>].</p><p>The extent to which diarrhea episodes become persistent is highly variable. Overall, fewer than 10 percent of episodes of diarrhea persist for two or more weeks, but reports range from 1.4 to 28.4 percent, and the risk depends on many factors, including the initial enteropathogen, nutritional status, geographical location, and socioeconomic conditions [<a href="#rid9">9,10</a>]. It is estimated that diarrhea lasting more than two weeks occurs in up to 3 to 5 percent of the infant population worldwide [<a href="#rid11">11</a>]. However, there is some evidence that the proportion of episodes of diarrhea that become persistent and the total number of children with persistent diarrhea is decreasing [<a href="#rid12">12</a>].</p><p>One report estimated that 1 million deaths could be averted annually by scaling up well-established preventive measures for diarrhea, including breastfeeding, <a class="drug drug_pediatric" data-topicid="12883" href="/z/d/drug information/12883.html" rel="external">vitamin A</a> supplementation, handwashing with soap, improved sanitation, safe drinking water, and rotavirus vaccination, as well as specific therapies, including <a class="drug drug_pediatric" data-topicid="119967" href="/z/d/drug information/119967.html" rel="external">oral rehydration solutions</a> (ORS), zinc, and antibiotics for dysentery [<a href="#rid13">13</a>]. More than one-half of these deaths are attributable to persistent diarrhea, and 30 to 50 percent of deaths occur among children younger than five years of age in resource-limited settings [<a href="#rid14">14-16</a>].</p><p class="headingAnchor" id="H4"><span class="h1">PATHOPHYSIOLOGY</span></p><p class="headingAnchor" id="H627058513"><span class="h2">General mechanisms of diarrhea</span><span class="headingEndMark"> — </span>The basic pathophysiology underlying all diarrheas is incomplete absorption of water and electrolytes from the intestinal lumen, either because of a reduced rate of net water absorption (related to impaired electrolyte absorption or excessive electrolyte secretion) or due to osmotic retention of water within the lumen. Reduction of net water absorption by as little as 1 percent may be sufficient to cause diarrhea. Consequently, even relatively modest compromise of absorptive function can lead to loose stools [<a href="#rid17">17</a>].</p><p>Diarrhea may result from pathology in the small intestine, the colon, or both and may have secretory and/or osmotic components.</p><p class="bulletIndent1"><span class="glyph">●</span>Secretory diarrhea (also known as electrolyte transport-related diarrhea) occurs when pathogens produce toxins that stimulate small intestinal secretion of chloride ions,<sup> </sup>with concomitant fluid movement into the intestinal lumen that overwhelms the absorptive capacity of the colon. The classic example is cholera and enterotoxigenic <em>Escherichia</em> <em>coli</em> infections. Pathogens that directly damage the small intestinal mucosa, such as norovirus, have a similar effect. Diarrhea may be severe, especially in the first two to three days. (See  <a class="medical medical_review" href="/z/d/html/5860.html" rel="external">"Pathogenesis of acute diarrhea in children", section on 'Electrolyte transport-related (secretory)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Osmotic diarrhea (also known as diet-induced diarrhea) occurs when unabsorbed nutrients (especially carbohydrates and sugars) or osmotically active medications cause an osmotic gradient that draws water into the intestinal lumen. This is by far the most common mechanism of acute infectious and persistent diarrhea. This may occur in the small or large intestine or both. This type of diarrhea is typically exacerbated by ingestion of carbohydrates or sugars, and stools may be acidic and contain reducing substances. Unabsorbed dietary fat does not exert the same osmotic effect, and steatorrhea is not necessarily associated with diarrhea. The colon has an important role in mitigating the effects of this type of diarrhea because much of the fluid secreted by the small intestine is reabsorbed in the colon. Additionally, short-chain fatty acids produced by bacteria are important because they facilitate fluid absorption by nonionic diffusion and serve as a metabolic fuel for colonocytes. Pathogens that cause inflammation of colonic mucosa classically cause frequent small diarrheal stools with blood and mucus. Inflammatory cells may be seen on microscopy of stools. All of these processes may occur together. (See  <a class="medical medical_review" href="/z/d/html/5860.html" rel="external">"Pathogenesis of acute diarrhea in children", section on 'Diet-induced (osmotic)'</a>.)</p><p></p><p class="headingAnchor" id="H2678373676"><span class="h2">Persistent diarrhea</span><span class="headingEndMark"> — </span>In resource-limited settings, most cases of persistent diarrhea are triggered by enteric infections but the condition is perpetuated by other factors such as malnutrition or immune suppression, as illustrated in the figure  (<a class="graphic graphic_figure graphicRef64008" href="/z/d/graphic/64008.html" rel="external">figure 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>First, the original infectious agent may be particularly virulent and difficult to clear. Some bacteria such as <em>Shigella</em> spp contain plasmids capable of downregulating the host cell expression of antibacterial peptides, thus delaying clearance of the bacteria [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Second, the infection may cause intestinal damage that leads to continuing diarrhea  (<a class="graphic graphic_figure graphicRef81123" href="/z/d/graphic/81123.html" rel="external">figure 2</a>). The most common example of this is secondary lactose intolerance, resulting from destruction of the villus tips where the enzyme lactase is located. Studies have also shown that intestinal damage leads to a decrease in intestinal absorptive surface area, which in turn interferes with the absorption of nutrients, particularly sugars [<a href="#rid19">19,20</a>]. Disturbance of the intestinal flora, such as occurs in antibiotic-associated diarrhea, is another example of a secondary effect. Also, irritable bowel syndrome develops in susceptible travelers following acute traveler's diarrhea.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Third, delayed healing of the intestine may prolong the diarrhea. Host factors, such as zinc, <a class="drug drug_pediatric" data-topicid="12883" href="/z/d/drug information/12883.html" rel="external">vitamin A</a>, or folate deficiency or generalized malnutrition impair the host response to the infection, resulting in longer duration. Recovery may be further impaired in individuals with underlying immunodeficiency conditions such as human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Finally, exposure to enteropathogens may be so common that new infections with different pathogens occur before the child has had a chance to recover, and these sequential acute episodes merge into one episode of persistent diarrhea.</p><p></p><p>These mechanisms are not exclusive and often exacerbate each other; for instance, delayed recovery makes it more likely that a new infection will lead to continuing symptoms.</p><p>Infection, malnutrition, and impaired immunity exacerbate one another  (<a class="graphic graphic_figure graphicRef81123" href="/z/d/graphic/81123.html" rel="external">figure 2</a>). Infection, anorexia, and food withdrawal or dilution reduce nutrient intake and cause increased net loss of nutrients, altered permeability, immune dysregulation, mucosal injury, altered intestinal microflora, and nutritional deficits [<a href="#rid21">21-23</a>]. These factors create a vicious cycle that leads to persistent diarrhea, with increasing malnutrition, and risk of death [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H548420915"><span class="h2">Environmental enteric dysfunction</span><span class="headingEndMark"> — </span>Environmental enteric dysfunction (EED), also known as environmental enteropathy, is a subclinical syndrome of altered enteric structure and function resulting in poor absorption, increased intestinal permeability, and chronic mucosal inflammation in individuals who live in resource-limited settings. In infants and children, EED has been implicated in both chronic childhood stunting and decreased immunogenicity of live oral vaccines [<a href="#rid25">25</a>]. It is caused by the interaction of enteric infections, malnutrition, and impaired host defense mechanisms  (<a class="graphic graphic_figure graphicRef64008" href="/z/d/graphic/64008.html" rel="external">figure 1</a>).</p><p>Although subclinical, EED is often associated with persistent low-grade malabsorption and is characterized by abnormalities and altered permeability of the small intestinal mucosa [<a href="#rid26">26</a>]. There is evidence of an inflammatory response in the mucosa with a variety of immunologic abnormalities [<a href="#rid14">14</a>]. In severe cases, the chronic enteropathy typically exhibits villous atrophy, with crypt cell hypoplasia with decreased mitotic figures [<a href="#rid27">27,28</a>]. The latter feature appears to be associated with protein malnutrition and sometimes helps to distinguish the disorder morphologically from celiac disease. The increased intestinal permeability, especially in children younger than 12 months, may lead to enhanced sensitization to dietary antigens and subsequent allergic enteropathy (see  <a class="medical medical_review" href="/z/d/html/5897.html" rel="external">"Food protein-induced allergic proctocolitis of infancy"</a>). In studies of EED patients in Bangladesh, Pakistan, and Zambia, intestinal biopsies reveal intestinal inflammation that is driven by an altered gut microbiome [<a href="#rid29">29-31</a>]. This appears to result in hypermethylation of genes related to epithelial metabolism and barrier function and hypomethylation of genes related to immune response and cell proliferation [<a href="#rid31">31</a>].</p><p>The enteropathy contributes to malnutrition by causing malabsorption of macronutrients and micronutrients due to reduced surface area for absorption, reduced bile acid production and function, impaired intestinal motility, and bacterial overgrowth. Small intestinal bacterial overgrowth (SIBO) is associated with increased intestinal permeability, especially in children younger than 12 months, which in turn may lead to enhanced sensitization to dietary antigens and an allergic enteropathy (see  <a class="medical medical_review" href="/z/d/html/5897.html" rel="external">"Food protein-induced allergic proctocolitis of infancy"</a>). However, SIBO is very common in children living in unhygienic environments and is found in asymptomatic children as well as those with acute and persistent diarrhea [<a href="#rid32">32</a>]. Although associated with nutrient malabsorption [<a href="#rid33">33</a>], it is not clear if and when SIBO per se causes diarrhea. It rapidly clears when clean food and water are provided.</p><p>Gut microbiota (the communities of bacteria present in the intestine) appear to play an important role in the pathogenesis of EED. This was shown in a group of Bangladeshi toddlers (mean age 18 months) with EED confirmed by an abnormal small bowel histology and characterized by linear growth stunting that was unresponsive to a nutritional intervention with no identifiable causative illness [<a href="#rid29">29</a>]. These children harbored strains of duodenal bacteria that are not classified as pathogens but were correlated with biomarkers of intestinal inflammation and stunting of growth. When these strains of bacteria were transferred to germ-free mice maintained on a multinutrient-deficient Bangladeshi diet, they induced histologic changes consistent with EED, supporting a causal mechanism; the control germ-free mice received cecal flora from conventional mice because ethical limitations precluded acquisition of duodenal bacteria from healthy children. In a subsequent study, targeted manipulation of gut flora in Bangladeshi children with moderate acute malnutrition using microbiota-directed complementary foods improved weight-for-age and weight-for-length recovery over a three-month trial [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/z/d/html/113959.html" rel="external">"Management of uncomplicated severe acute malnutrition in children in resource-limited settings", section on 'Formulations'</a>.)</p><p>Gut microbiota, interacting with dietary factors, also appear to be involved in the pathogenesis of acute malnutrition, particularly kwashiorkor [<a href="#rid35">35</a>]. Together, these findings suggest that gut dysbiosis may be involved in the pathogenesis of EED, persistent diarrhea, and acute or chronic malnutrition. (See  <a class="medical medical_review" href="/z/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment", section on 'Pathophysiology'</a>.)</p><p class="headingAnchor" id="H548420954"><span class="h2">Contributing factors</span></p><p class="headingAnchor" id="H5"><span class="h3">Enteric pathogens</span><span class="headingEndMark"> — </span>A large variety of bacterial pathogens have been isolated from stools of children with persistent diarrhea in resource-limited settings. Some pathogens have been associated with more prolonged episodes, although results of studies are inconsistent. A literature review identified more than 30 bacterial, viral, and parasitic potential pathogens in persistent digestive disorders including persistent diarrhea. Among the most commonly cited culprits are enteroaggregative <em>E</em>. <em>coli</em> (also known as enteroadherent <em>E</em>. <em>coli</em>) [<a href="#rid14">14,36-38</a>], enteropathogenic <em>E</em>. <em>coli</em> in infants younger than six months [<a href="#rid3">3,39-41</a>], <em>Shigella</em> [<a href="#rid42">42</a>], <em>Cryptosporidium</em> [<a href="#rid43">43</a>], <em>Yersinia</em>, and <em>Campylobacter</em>. (See  <a class="medical medical_review" href="/z/d/html/2720.html" rel="external">"Pathogenic Escherichia coli associated with diarrhea"</a> and  <a class="medical medical_review" href="/z/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings", section on 'Infectious causes'</a>.)</p><p>Intestinal parasites such as <em>Cyclospora</em>, <em>Isospora</em>, <em>Microsporidium</em>, <em>Entamoeba</em> <em>histolytica</em>, and <em>Strongyloides</em> may also play a role [<a href="#rid14">14</a>]. Among the intestinal parasites, <em>Cryptosporidium</em> has been found in chronic episodes of diarrhea in Bangladesh but not in Peru, while <em>Giardia</em> <em>lamblia</em> showed similar incidence rates in acute and chronic diarrhea [<a href="#rid24">24,44-46</a>]. (See  <a class="medical medical_review" href="/z/d/html/6024.html" rel="external">"Giardiasis: Treatment and prevention"</a>.)</p><p>Twelve different types of viruses have been implicated, including adenovirus, norovirus, cytomegalovirus, human rotavirus, and HIV [<a href="#rid38">38,42</a>]. Viral pathogens such as rotavirus and cytomegalovirus have been associated with protracted diarrhea, usually following particularly severe acute episodes [<a href="#rid44">44,47,48</a>]. Rotavirus is the principal cause of severe acute, dehydrating diarrhea in young children, but most episodes of rotavirus infection are short lived and self-limited. Nevertheless, rotavirus has been implicated in protracted diarrhea syndrome in both immunodeficient and immunocompetent hosts [<a href="#rid49">49,50</a>]. The reduction in diarrheal episodes associated with introduction of a vaccine against rotavirus in the infant vaccine schedules of many countries will allow a better estimate of the effect of this virus in persistent diarrhea. (See  <a class="medical medical_review" href="/z/d/html/5984.html" rel="external">"Acute viral gastroenteritis in children in resource-abundant countries: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2681.html" rel="external">"Clinical manifestations and diagnosis of rotavirus infection", section on 'Clinical manifestations'</a>.)</p><p><em>Torovirus</em> and <em>Astrovirus</em> also have been associated with chronic diarrhea [<a href="#rid51">51,52</a>]. Some viral infections such as measles or HIV cause chronic diarrhea through immunosuppression [<a href="#rid53">53,54</a>]. Immunosuppressed children are more likely to develop enteric infections with multiple pathogens and/or with opportunistic pathogens such as <em>Mycobacterium</em> <em>avium</em> complex, <em>Isospora</em>, and microsporidia [<a href="#rid55">55</a>]. (See  <a class="medical medical_review" href="/z/d/html/5963.html" rel="external">"Pediatric HIV infection: Classification, clinical manifestations, and outcome", section on 'Other'</a>.)</p><p>However, serial stool cultures during episodes of chronic diarrhea suggest that sequential infections with the same or different pathogens are more often responsible for prolonged diarrhea [<a href="#rid44">44,45</a>] than persistence of a single etiologic agent. When complete analyses are undertaken, multiple pathogens often are identified. Studies in resource-limited settings where fecal contamination is common show high rates of enteropathogens, even in stools of children without diarrhea [<a href="#rid36">36</a>]. Therefore, the presence of a particular bacteria, virus, or parasite does not mean it is the causal agent, perhaps explaining some apparent treatment failures. On the other hand, no enteropathogens are detected in many cases of persistent diarrhea [<a href="#rid14">14,36</a>]. This may be because it is almost impossible to test for all possible pathogens, particularly in resource-limited settings; because the pathogen is intermittently excreted or was present during the acute phase of the diarrhea; or because the diarrhea has a noninfectious cause.</p><p>Advances in genetics are increasing understanding of the interaction between the virulence mechanisms of enteropathogens and the host immune response, and are likely to explain why some children have persistent diarrhea, whereas others harboring the same pathogens remain symptom-free [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H6"><span class="h3">Malnutrition</span><span class="headingEndMark"> — </span>Chronic and acute undernutrition impair the development and function of the immune system [<a href="#rid57">57</a>]. This leads to suboptimal immune responses that are also associated with a generalized increase in inflammatory mediators, which can contribute to the tissue damage caused by enteric infection. Malnutrition also impairs tissue repair mechanisms so that infections tend to be more severe and of longer duration.</p><p>Specific nutrient deficiencies, such as <a class="drug drug_pediatric" data-topicid="12883" href="/z/d/drug information/12883.html" rel="external">vitamin A</a> and zinc deficiencies, are associated with persistent diarrhea [<a href="#rid58">58-60</a>]. Randomized controlled studies in a variety of populations have shown that zinc supplementation given during an episode of diarrhea reduces the severity and duration of acute and persistent diarrhea in children over six months of age [<a href="#rid61">61</a>]. Zinc supplements given prophylactically in populations where zinc deficiency is common also reduce the incidence of diarrhea, including persistent diarrhea [<a href="#rid62">62-64</a>]. (See  <a class="medical medical_review" href="/z/d/html/5354.html" rel="external">"Zinc deficiency and supplementation in children"</a>.)</p><p>Breastfeeding, especially exclusive breastfeeding, protects against diarrhea through reduced exposure to enteropathogens and provides protective substances including lactoferrin, lysozyme, and oligosaccharides against enteropathogens, as well as maternal antibodies and white blood cells. Both acute and persistent diarrhea is less common in breastfed children. The positive effects of breastfeeding continue even after other foods are introduced; breastfeeding to two years old is the recommendation by the World Health Organization (WHO) and other agencies [<a href="#rid65">65,66</a>].</p><p class="headingAnchor" id="H8"><span class="h3">HIV disease</span><span class="headingEndMark"> — </span>Persistent diarrhea is commonly associated with HIV and provides a paradigm for the complex interactions between the immunocompromised host, malnutrition, and enteric infection. Malnutrition is often an early manifestation of HIV disease and is associated with a rapid decrease in the CD4+ cell number and an increased rate of opportunistic infections [<a href="#rid67">67</a>]. Combined dysfunctions of the digestive-absorptive processes are common in children with HIV infection and may involve the intestine, liver, and pancreas [<a href="#rid68">68</a>]. Iron and lactose malabsorption are particularly common [<a href="#rid69">69</a>].</p><p>Several cellular mechanisms appear to be directly affected by HIV infection. As an example, the HIV transactivating factor protein (Tat) released by the virus can directly impact enterocytes, both as a viral cytotoxin and an enterotoxin. This protein-cell interaction impairs cell growth and proliferation and inhibits ion transport [<a href="#rid70">70</a>]. In the setting of immunosuppression, superinfection with opportunistic agents such as <em>Cryptosporidium</em>, <em>Blastocystis</em> <em>hominis</em>, <em>Candida</em> <em>albicans</em>, and others can lead to diarrhea and mucosal injury. Consequently, HIV infection both directly and indirectly induces intestinal dysfunction, malnutrition, and immune impairment. Antiretroviral therapy may also cause persistent diarrhea [<a href="#rid71">71</a>].</p><p class="headingAnchor" id="H9"><span class="h1">DIAGNOSTIC APPROACH</span><span class="headingEndMark"> — </span>Because persistent diarrhea following an acute infection is the predominant type of diarrhea seen in resource-limited settings and because diagnostic resources often will be limited, an diagnostic and management algorithm is practical and usually effective. This approach requires categorical assessment of the child's nutritional status and type of diarrhea, specific testing for pathogens when possible, and, in some cases, empiric therapy based on the clinical findings and prevalence rates.</p><p class="headingAnchor" id="H10"><span class="h2">Assess for complications and comorbid conditions</span><span class="headingEndMark"> — </span>The first step in the evaluation is to assess the child for dehydration and sepsis, as both require urgent treatment.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dehydration</strong> – Follow standard guidelines to diagnose and treat hypovolemia (dehydration) (see  <a class="medical medical_review" href="/z/d/html/6142.html" rel="external">"Clinical assessment of hypovolemia (dehydration) in children"</a>). Children with mild or no dehydration should be given extra fluids and can be managed at home; moderate dehydration should be treated orally or by nasogastric tube, using a rehydration fluid consisting of glucose, sugar or rice flour, sodium, <a class="drug drug_pediatric" data-topicid="13037" href="/z/d/drug information/13037.html" rel="external">potassium chloride</a>, and a base such as bicarbonate or citrate. It is important to continue oral feeding even if the diarrhea continues. (See <a class="local">'Rehydration'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malnutrition</strong> – Children should be weighed, measured, and examined for bilateral edema in order to recognize severe malnutrition that will require special attention  (<a class="graphic graphic_table graphicRef60869" href="/z/d/graphic/60869.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment"</a>.)</p><p></p><p class="bulletIndent1">Children with diarrhea and severe malnutrition (&lt;70 percent of median reference weight for height or mid-upper arm circumference &lt;115 mm), and especially those with edematous malnutrition, fever, or other signs of medical complications, should be evaluated and managed in a specialized treatment center whenever possible. Management of children with malnutrition is discussed in detail in separate topic reviews. (See  <a class="medical medical_review" href="/z/d/html/117772.html" rel="external">"Management of moderate acute malnutrition in children in resource-limited settings"</a> and  <a class="medical medical_review" href="/z/d/html/113959.html" rel="external">"Management of uncomplicated severe acute malnutrition in children in resource-limited settings"</a> and  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infections</strong> – All children should be evaluated for nonintestinal infections, including otitis media, pneumonia, urinary tract infections, and sepsis. Treatment of these infections should follow standard protocols.</p><p></p><p>Clinicians should look for comorbid conditions that may be the underlying cause of the malnutrition, such as cerebral palsy, cystic fibrosis, congenital heart disease, HIV disease, and tuberculosis. These diseases may cause or complicate the child’s illness and nutritional status. Tuberculosis may be difficult to diagnose in severely malnourished children. (See  <a class="medical medical_review" href="/z/d/html/8020.html" rel="external">"Tuberculosis infection (latent tuberculosis) in children"</a> and  <a class="medical medical_review" href="/z/d/html/8007.html" rel="external">"Tuberculosis disease in children: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Categorize the diarrhea</span><span class="headingEndMark"> — </span>The next step is to classify the diarrhea based on its appearance; this is not essential as a first step but narrows the range of likely infectious agents and provides some estimate of risk.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Watery diarrhea</strong> – Most cases of persistent watery diarrhea in children in resource-limited settings are caused by acute infections with enteric pathogens, usually in combination with undernutrition. These children usually respond to interventions designed to improve nutrition and reduce the likelihood of reinfection. Because serial infections are common, enteropathogens not usually associated with persistent diarrhea may present as acute or chronic infections. As an example, cholera typically presents with acute-onset watery diarrhea in children or adults (often with vomiting). In children younger than two years of age, the clinical presentation is not readily distinguishable from that of rotavirus. Cholera should be suspected in a child presenting with an acute exacerbation of watery, chronic diarrhea if other cases of cholera are reported in the area.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bloody diarrhea</strong> – In resource-limited settings, most cases of acute bloody diarrhea are caused by <em>Shigella</em> spp (45 to 67 percent of cases) and <em>Campylobacter</em> (35 to 37 percent of cases) [<a href="#rid72">72</a>]. <em>E</em>. <em>histolytica</em> is the most important nonbacterial pathogen but is responsible for fewer than 3 percent of episodes. Most infections with these organisms result in acute diarrhea illnesses and cause low-volume bloody stools, often associated with fever. However, in children with underlying malnutrition or immunodeficiency, these pathogens may cause chronic diarrhea and may be associated with higher-volume diarrhea and dehydration. Children presenting with bloody diarrhea are at particularly high risk for morbidity and mortality [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>Specific laboratory testing is not essential for the management of persistent diarrhea in resource-limited settings. Essential fluid, electrolyte, and dietary management are not dependent on etiology. There are rarely facilities for a complete enteropathic screen, and results of stool cultures are generally not available in time to be clinically valuable for these patients.</p><p>Nonetheless, some simple bedside laboratory tests may be helpful. In cases where diarrhea has persisted for more than two weeks, testing the stool for glucose and pH can be helpful in identifying those children with severe villous atrophy. This can be done easily at the bedside with a urine dipstick if available. Glucose test tape, nitrazine paper, and Clinitest tablets also have been used. A stool glucose of greater than 2+ or a pH of less than 5.0 suggests substantial villous atrophy.</p><p>In selected cases, laboratory testing also can help identify enteropathogens that respond to antimicrobial therapy. If the diarrhea contains red blood or blood mixed with mucus and facilities are available, the stool should be cultured for bacterial pathogens (particularly <em>Shigella</em> spp and <em>Campylobacter</em>). In these cases, antibiotic treatment for <em>Shigella</em> infection, based on local resistance patterns, should be started empirically (see <a class="local">'Antimicrobials'</a> below). In some clinical settings, laboratory testing is used as surveillance for epidemiologic reasons, such as the detection of cholera outbreaks.</p><p>For children with persistent watery stools, stool microscopy can be performed to detect trophozoites or cysts of <em>E</em>. <em>histolytica</em> or other parasites. However, microscopy typically over-diagnoses amoebiasis because of the difficulty of distinguishing pathologic from nonpathologic <em>Entamoeba</em>. If available, fecal antigen assays also may be used to detect <em>Giardia</em> infection. Rotavirus should also be sought, and rapid tests are now available in many locales. (See  <a class="medical medical_review" href="/z/d/html/5723.html" rel="external">"Giardiasis: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p>If cholera is suspected (eg, in a child presenting with an acute exacerbation of diarrhea, with "rice-water" stools and vomiting), dark-field or phase-contrast microscopy can be performed to identify the organism. Antimicrobial therapy generally is not necessary for individuals with mild symptoms, so there is no benefit to specific testing for these patients. (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of chronic diarrhea includes supportive measures, nutritional rehabilitation, and drug therapy. Children with diarrhea and moderate malnutrition, evidence of dehydration, or systemic infections; infants younger than six months of age; and children with severe persistent diarrhea should be treated in an inpatient setting if possible [<a href="#rid73">73</a>]. Children with severe malnutrition also should be treated as inpatients until stable, as described separately. (See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings"</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Rehydration</span><span class="headingEndMark"> — </span>Death in the context of persistent diarrhea is usually caused either by hypovolemia (dehydration) and/or severe acute malnutrition (defined as &lt;70 percent of median reference weight for height or mid-upper arm circumference &lt;115 mm). Consequently, replacement of fluid and electrolyte losses is the major early intervention.</p><p>Rehydration is ideally given through the oral or nasogastric route with an oral rehydration solution (ORS) [<a href="#rid74">74</a>]. The World Health Organization (WHO) recommends different formulations of ORS for different groups of children:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>No malnutrition, uncomplicated malnutrition, and/or cholera</strong> – For these children, use standard <a class="external" href="/external-redirect?target_url=http%3A%2F%2Frehydrate.org%2Fors%2Fexpert-consultation.html&amp;token=R8m6dCN7jI5sBUDFIPII4EEdgwBjH3tzzKFlujpEFqLRoGYaooCwsK6q7kixzTSMI%2BoD0SJocOFaqkLrQtoQUA%3D%3D&amp;TOPIC_ID=5878" target="_blank">low-osmolarity ORS</a> to treat diarrheal episodes [<a href="#rid73">73</a>]. This solution contains 75 mmol/L glucose, 75 mEq/L sodium, and 20 mEq/L potassium, at an osmolarity of 245 mOsm/L [<a href="#rid75">75</a>]. Severe acute malnutrition is considered uncomplicated if the child is clinically well, alert, and has retained their appetite.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complicated severe acute malnutrition</strong> – For children with complicated severe acute malnutrition (ie, with clinical features of infection or metabolic disturbance, severe edema, or poor appetite), the preferred rehydration solution is <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmedicalguidelines.msf.org%2Fen%2Fviewport%2FEssDr%2Fenglish%2Fresomal-rehydration-solution-for-malnutrition-oral-16684569.html&amp;token=CYuh9An51QQHJ76WznnKowDc6A4ROEHXj%2BXdUTh1x2%2FRGWQ3dhL7eJXzUOaO2Q%2BifBSV72VMztMmh7EMNvBpGy1cutimun0Nr1P17g%2FHSkMXJp8qVgldeV%2Bf8M4RBCg1oPlfwJ6ktx6LmSKHPYojaQ%3D%3D&amp;TOPIC_ID=5878" target="_blank">ReSoMal</a> (Rehydration Solution for Malnourished children) [<a href="#rid76">76,77</a>]. This formula contains 55 mmol/L glucose, 45 mEq/L sodium, and 40 mEq/L potassium, at an osmolarity of 294 mEq/L. This is because severely malnourished children are potassium depleted. If ReSoMal is not available, additional sucrose and <a class="drug drug_pediatric" data-topicid="13037" href="/z/d/drug information/13037.html" rel="external">potassium chloride</a> can be added to the standard low-osmolarity ORS fluid to provide 40 mEq/L of potassium; the method is described separately. (See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Rehydration Solution for Malnutrition (ReSoMal)'</a>.)</p><p></p><p class="bulletIndent1">If ReSoMal (or the formulated equivalent) is not available, it is acceptable to use standard low-osmolarity ORS for children with complicated severe acute malnutrition [<a href="#rid73">73</a>]. (See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Oral rehydration solution'</a>.)</p><p></p><p>In most cases, breastfeeding should be continued. The evaluation of a child for dehydration and treatment with ORS according to the degree of dehydration are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6129.html" rel="external">"Oral rehydration therapy"</a> and  <a class="medical medical_review" href="/z/d/html/5883.html" rel="external">"Malnutrition in children in resource-limited settings: Clinical assessment"</a>.)</p><p>Children with severe dehydration (eg, hypovolemic shock) may require intravenous fluids, as described separately and in standard protocols. For those with severe acute malnutrition, and especially for those with edematous malnutrition, intravenous fluids should be carefully monitored to avoid overhydration and risk for heart failure. (See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Rehydration methods'</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Dietary management</span><span class="headingEndMark"> — </span>Nutritional compromise plays a role in most cases of persistent diarrhea in resource-limited settings and is the primary target for treatment.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>General approach</strong> – It is essential to start oral feeding as soon as the child has been rehydrated. Delays in starting feeding worsen malnutrition. At first, the diet should be given in frequent small amounts (for instance, every three hours), in which the total amount mentioned above is divided into eight feedings. If children refuse food, a nasogastric tube may be necessary. Feeding should be continued, either orally or by nasogastric tube, during the night to avoid long periods without food. This approach is similar to that used for nutritional rehabilitation in other children with malnutrition.</p><p></p><p class="bulletIndent1">For patients with severe malnutrition, management typically includes a gradual increase to full caloric intake, with a course of broad-spectrum antibiotics. Hypophosphatemia is common during the early phases of refeeding (known as "refeeding syndrome") and can be mitigated by feeds that are relatively high in phosphorus (eg, milk-based feeds). Measurement of serum phosphorus concentrations is not routinely available in most centers managing acute malnutrition in resource-limited settings. (See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diet composition</strong> – Most children will respond to dietary management using locally available foods designed to provide approximately 150 kcals/kg/day and 10 percent of calories from protein [<a href="#rid78">78</a>]. If possible, at least one-half the protein should come from an animal source such as milk, egg, or chicken. Additional potassium should be added to the diet to provide at least 5 mEq/kg per day. Breastfeeding may provide some of these nutrients and is continued when possible.</p><p></p><p class="bulletIndent1">Many infants and children with chronic diarrhea have secondary disaccharidase deficiencies caused by mucosal damage. Consequently, a low-lactose diet and sometimes a diet also low in sucrose or total carbohydrates may be necessary. It is often sufficient to reduce lactose by mixing milk with cereals such as rice or noodles and giving small frequent feedings. However, a minority of children benefit from a lactose-free diet. Egg or pureed chicken has been successfully used and is palatable. Yogurt-based diets have also been used successfully [<a href="#rid79">79</a>]. Lactose-free formulas are an alternative if available, but it is important to ensure that the family can afford these formulas and will not dilute or give less than the required amounts in order to save money.</p><p></p><p class="bulletIndent1">There is no need to limit fat intake; indeed, fat can be beneficial because it provides concentrated calories and enables less carbohydrate to be included in the diet. Ready-to-use therapeutic food (RUTF) is not contraindicated. In a randomized trial of 250 children in southern India with acute watery diarrhea, supplementation with cooked green bananas hastened recovery and reduced the risk of progression to persistent diarrhea by 70 percent [<a href="#rid80">80</a>]. In a similar trial of 153 children in eastern India, supplementation with green bananas reduced the duration of diarrhea by 1.5 days and reduced the risk of progression to persistent diarrhea by 60 percent [<a href="#rid81">81</a>]. Green bananas are a rich source of pectin, a starch that resists digestion and is converted in the colon to short-chain fatty acids, which are thought to have cytoprotective effects and enhance colonic fluid absorption.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy</strong> – The efficacy of dietary management, with an algorithm for lactose inclusion, was demonstrated in a multinational trial designed by the WHO [<a href="#rid78">78</a>]. After evaluation and treatment for acute comorbidities (including hypovolemia, sepsis, and pneumonia), all children were treated with a low-lactose diet, containing &lt;3.7 grams of lactose/150 kcals, as compared with approximately 10 grams of lactose/150 kcals in the standard WHO full-milk diet. The ingredients varied by region but consisted of cereals, legumes, vegetable oil, and milk products, with added micronutrient supplements and an energy density of 65 to 100 kcals/100 grams. Children who did not respond to this low-lactose diet within seven days were advanced to a lactose-free diet, in which the protein component was supplied by chicken or egg white. The overall success rate for the treatment algorithm was 80 percent (95% CI 76-84 percent). Sixty-five percent of children recovered with a low-lactose diet alone. Among the 35 percent of children who failed the low-lactose diet and moved on to treatment with a lactose-free diet, 71 percent recovered on this diet.</p><p></p><p class="headingAnchor" id="H16"><span class="h2">Micronutrients and vitamins</span><span class="headingEndMark"> — </span>Micronutrient and vitamin supplementation are part of nutritional rehabilitation, especially in malnourished children from resource-limited settings [<a href="#rid59">59,60</a>]. Children with chronic diarrhea and malnutrition are often deficient in <a class="drug drug_pediatric" data-topicid="12883" href="/z/d/drug information/12883.html" rel="external">vitamin A</a>, zinc, <a class="drug drug_pediatric" data-topicid="13322" href="/z/d/drug information/13322.html" rel="external">folic acid</a>, copper, and other vitamins and minerals [<a href="#rid82">82</a>]. Deficiencies in these micronutrients can impair the function of the immune system and have a direct effect on small intestinal function and recovery.</p><p>The WHO recommends zinc supplementation for children with diarrhea in resource-limited settings, at a dose of 10 mg daily for infants up to six months of age and 20 mg daily for older infants and children, for 14 days [<a href="#rid62">62,83</a>]. These recommendations are based on a variety of randomized trials in resource-limited settings, demonstrating that zinc supplementation reduced the severity and duration of acute and persistent diarrhea in children [<a href="#rid63">63,64,84</a>]. A subsequent large trial found that lower doses of zinc (10 mg or 5 mg daily for children &gt;6 months) were equally effective for treating the diarrhea compared with the standard 20 mg dose and reduced the risk of vomiting [<a href="#rid85">85</a>]. In July 2019, the WHO added zinc to its Model List of Essential Medicines for Children listings, both as co-packaged oral rehydration salts (with 5 mg elemental zinc/sachet) and as <a class="drug drug_pediatric" data-topicid="88581" href="/z/d/drug information/88581.html" rel="external">zinc sulfate</a> for acute diarrhea (20 mg) [<a href="#rid86">86</a>]. (See  <a class="medical medical_review" href="/z/d/html/5354.html" rel="external">"Zinc deficiency and supplementation in children", section on 'Treatment of acute or persistent diarrhea'</a>.)</p><p>In addition to zinc, the WHO also recommends providing at least two times the recommended daily allowance for folate, <a class="drug drug_pediatric" data-topicid="12883" href="/z/d/drug information/12883.html" rel="external">vitamin A</a>, iron, copper, and magnesium for two weeks [<a href="#rid87">87</a>]. Vitamin A and zinc supplementation may have synergistic effects [<a href="#rid60">60</a>]. In addition, children with concomitant measles infection or ophthalmologic signs of vitamin A deficiency should be treated with a high dose of vitamin A. (See  <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Vitamin A'</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Antimicrobials</span><span class="headingEndMark"> — </span>Although nutritional rehabilitation is effective alone for most children with chronic diarrhea, specific antibiotic treatment for enteric pathogens is indicated in some cases, particularly children with bloody diarrhea (usually caused by <em>Shigella</em>, <em>Campylobacter</em>, or parasites) [<a href="#rid88">88</a>].</p><p>Children with bloody diarrhea are likely to have a <em>Shigella</em> or <em>Campylobacter</em> infection and can be treated empirically [<a href="#rid89">89</a>]. Empiric therapy generally should be directed against <em>Shigella</em>, based on the known sensitivities of local strains. <a class="drug drug_pediatric" data-topicid="13157" href="/z/d/drug information/13157.html" rel="external">Ciprofloxacin</a>, <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">ceftriaxone</a>, and <a class="drug drug_general" data-topicid="118047" href="/z/d/drug information/118047.html" rel="external">pivmecillinam</a> have been shown to be generally effective [<a href="#rid90">90</a>]. If no improvement is seen within two days, treatment should be changed to another agent known to be effective against local strains of <em>Shigella</em> [<a href="#rid87">87</a>]. Antimicrobial therapy for <em>Campylobacter</em> is only indicated in patients who are at increased risk or have severe disease, with bloody stools, high fever, or symptoms lasting longer than one week. (See  <a class="medical medical_review" href="/z/d/html/6003.html" rel="external">"Shigella infection: Treatment and prevention in children", section on 'Antibiotic therapy'</a> and  <a class="medical medical_review" href="/z/d/html/2715.html" rel="external">"Campylobacter infection: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p>Antibiotics are not essential for treatment of cholera but may hasten recovery and reduce the duration of infectivity. Thus, antimicrobial therapy directed against cholera is recommended for cases of suspected or proven cholera with severe dehydration [<a href="#rid87">87</a>]. (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p>If enteric parasites are identified by laboratory testing, these should be treated according to standard guidelines. Empiric therapy for intestinal parasites is not recommended, except that empiric treatment for amoebiasis may be considered in a child with persistent bloody diarrhea, who has failed trials of two different antimicrobials known to be effective against local strains of <em>Shigella</em> [<a href="#rid87">87</a>]. In addition, <a class="drug drug_pediatric" data-topicid="12904" href="/z/d/drug information/12904.html" rel="external">nitazoxanide</a> has been shown to have partial efficacy in treatment of cryptosporidiosis in undernourished children in low-resource settings but not in children with HIV/AIDS. (See  <a class="medical medical_review" href="/z/d/html/6024.html" rel="external">"Giardiasis: Treatment and prevention"</a> and  <a class="medical medical_review" href="/z/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a> and  <a class="medical medical_review" href="/z/d/html/5724.html" rel="external">"Cyclospora infection"</a> and  <a class="medical medical_review" href="/z/d/html/16217.html" rel="external">"Cryptosporidiosis: Treatment and prevention"</a>.)</p><p>Extraintestinal infections such as acute lower respiratory infections, urinary tract infections, sepsis, and others are commonly associated with chronic diarrhea and should be evaluated carefully and treated promptly [<a href="#rid78">78,91,92</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Antidiarrheal drugs</span><span class="headingEndMark"> — </span>Drugs that alter intestinal motility, including <a class="drug drug_pediatric" data-topicid="12561" href="/z/d/drug information/12561.html" rel="external">loperamide</a>, <a class="drug drug_pediatric" data-topicid="13178" href="/z/d/drug information/13178.html" rel="external">codeine</a>, and <a class="drug drug_pediatric" data-topicid="12679" href="/z/d/drug information/12679.html" rel="external">paregoric</a>, are not recommended, because they lack efficacy, are associated with potentially serious side effects, and possibly prolong the excretion of enteric pathogens [<a href="#rid15">15,83</a>]. Similarly, some antiemetics may cause sedation that could interfere with oral rehydration therapy and should not be given to children with diarrhea [<a href="#rid87">87</a>]. (See  <a class="medical medical_review" href="/z/d/html/5881.html" rel="external">"Approach to chronic diarrhea in children &gt;6 months in resource-abundant settings", section on 'Medications'</a>.)</p><p class="headingAnchor" id="H7068392"><span class="h2">Probiotics</span><span class="headingEndMark"> — </span>A Cochrane review of clinical trials reported that probiotics reduced the stool frequency and duration of persistent diarrhea [<a href="#rid93">93</a>]. The authors concluded that probiotics appeared to hold promise as adjuvant therapy for persistent diarrhea, but there was insufficient evidence to recommend their use at this time. The probiotics used in the trials were <a class="drug drug_pediatric" data-topicid="13404" href="/z/d/drug information/13404.html" rel="external">Lactobacillus</a> strains plus <em>Saccharomyces</em> <em>boulardii</em> and <em>Lactobacillus</em> <em>rhamnosus</em> GG. A subsequent randomized, double-blind, placebo-controlled study in Uganda involved 400 children admitted to the hospital with severe acute malnutrition [<a href="#rid94">94</a>]. <em>Bifidobacterium</em> <em>animalis</em> subsp. <em>lactis</em> and <em>L</em>. <em>rhamnosus</em> had no effect on diarrhea during the hospitalization for severe acute malnutrition but reduced the number of days with diarrhea after discharge to outpatient treatment by 26 percent.</p><p class="headingAnchor" id="H4011010541"><span class="h2">Pancreatic enzyme replacement therapy</span><span class="headingEndMark"> — </span>A small study from Indonesia used fecal elastase-1 to identify pancreatic exocrine insufficiency in 31 children with persistent diarrhea with or without malnutrition and randomized them to treatment with pancreatic enzyme replacement therapy (8371 United States Pharmacopeia [USP] units of lipase three times daily for one month) versus placebo, as an adjunct to standard treatment [<a href="#rid95">95,96</a>]. Patients treated with pancreatic enzymes had significantly shorter duration of diarrhea compared with placebo (3 versus 10 days; p = 0.019).</p><p class="headingAnchor" id="H1025986983"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/110029.html" rel="external">"Society guideline links: Acute diarrhea in children"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/110738.html" rel="external">"Society guideline links: Pediatric malnutrition"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Persistent diarrhea is defined as loose or watery stools occurring at least three times a day for 14 days or more, where the change in stool consistency is more important than stool frequency. This typically translates to a stool volume of more than 10 grams/kg/day in infants and toddlers, or more than 200 grams/day in older children. (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes</strong> – In resource-limited settings, most cases of persistent diarrhea are caused by a combination of enteric infections, undernutrition, and impaired immunity  (<a class="graphic graphic_figure graphicRef81123" href="/z/d/graphic/81123.html" rel="external">figure 2</a>). These factors interact to cause a chronic enteropathy and diarrhea. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The first step in evaluating a child with persistent diarrhea is to diagnose comorbid conditions that may cause or complicate the diarrheal illness, including dehydration, malnutrition, and associated nonenteric infections, including sepsis and HIV disease. (See <a class="local">'Assess for complications and comorbid conditions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The next step is to classify the diarrhea based on its appearance. Bloody diarrhea is most likely caused by <em>Shigella</em>, confers a worse prognosis, and requires antimicrobial treatment. An acute exacerbation of watery diarrhea should raise the possibility of cholera in children older than two years of age. (See <a class="local">'Categorize the diarrhea'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Laboratory testing of stool is not essential for management. When available, it may be helpful to test the stools for the presence of glucose or acidic pH, culture bloody stools for <em>Shigella</em> and <em>Campylobacter</em>, and examine stools for parasites including <em>Giardia</em>, <em>Cryptosporidium</em>, and <em>Entamoeba</em> <em>histolytica</em>. (See <a class="local">'Laboratory testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stabilization</strong> – The first step in treatment is to stabilize children with dehydration or intercurrent infections:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rehydration</strong> – Children with mild or moderate dehydration and all children with suspected cholera should be treated with standard low-osmolarity oral rehydration solution (ORS). For those with complicated severe acute malnutrition, the preferred rehydration solution is ReSoMal, which has higher potassium content compared with standard ORS. Children with severe dehydration and hypovolemic or septic shock may require intravenous repletion. (See <a class="local">'Rehydration'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment of intercurrent infections</strong> – Intercurrent infections (otitis media, pneumonia, urinary tract infections) should be managed according to standard protocols.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of diarrhea</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotics</strong> – For treatment of the diarrhea, we generally suggest <strong>not</strong> treating empirically with antibiotics (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). However, in children with bloody diarrhea, we suggest empiric therapy directed against <em>Shigella</em> (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). We also suggest antimicrobial treatment for patients with severe symptoms and suspected or proven cholera or <em>Cryptosporidium</em> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Antibiotics should be selected based on sensitivities of local strains. If this information is not available, <a class="drug drug_pediatric" data-topicid="13157" href="/z/d/drug information/13157.html" rel="external">ciprofloxacin</a>, <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">ceftriaxone</a>, or <a class="drug drug_general" data-topicid="118047" href="/z/d/drug information/118047.html" rel="external">pivmecillinam</a> is recommended. (See <a class="local">'Antimicrobials'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nutritional rehabilitation</strong> – The main component of treatment is nutritional rehabilitation. Breastfeeding is continued when possible and supplemented with a balanced diet of locally available foods, including an animal protein source such as yogurt, milk, chicken, or egg. Many children with chronic enteropathy have a secondary carbohydrate intolerance and respond better to a low-lactose or low-carbohydrate diet. (See <a class="local">'Dietary management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Zinc</strong> – Children with chronic diarrhea in resource-limited settings should be treated with zinc supplements, consistent with guidance from the World Health Organization (WHO). The evidence and implementation are discussed separately. (See <a class="local">'Micronutrients and vitamins'</a> above and  <a class="medical medical_review" href="/z/d/html/5354.html" rel="external">"Zinc deficiency and supplementation in children", section on 'Treatment of acute or persistent diarrhea'</a>.)</p><p></p><p class="headingAnchor" id="H107889160"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Mary E Penny, MBChB, MRCP, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bhutta ZA, Ghishan F, Lindley K, et al. Persistent and chronic diarrhea and malabsorption: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39 Suppl 2:S711.</a></li><li><a class="nounderline abstract_t">Binder HJ. Causes of chronic diarrhea. N Engl J Med 2006; 355:236.</a></li><li><a class="nounderline abstract_t">Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr Program 2007; 59:89.</a></li><li><a class="nounderline abstract_t">Mbori-Ngacha DA, Otieno JA, Njeru EK, Onyango FE. Prevalence of persistent diarrhoea in children aged 3-36 months at the Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J 1995; 72:711.</a></li><li><a class="nounderline abstract_t">Vanderhoof JA. Chronic diarrhea. Pediatr Rev 1998; 19:418.</a></li><li><a class="nounderline abstract_t">Moore SR, Lima NL, Soares AM, et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 2010; 139:1156.</a></li><li><a class="nounderline abstract_t">Baqui AH, Black RE, Yunus M, et al. Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol 1991; 20:1057.</a></li><li><a class="nounderline abstract_t">Johnston BC, Shamseer L, da Costa BR, et al. Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010; 126:e222.</a></li><li><a class="nounderline abstract_t">Andrade JA, Fagundes-Neto U. Persistent diarrhea: still an important challenge for the pediatrician. J Pediatr (Rio J) 2011; 87:199.</a></li><li><a class="nounderline abstract_t">Mathai J, Raju B, Bavdekar A, Pediatric Gastroenterology Chapter, Indian Academy of Pediatrics. Chronic and persistent diarrhea in infants and young children: status statement. Indian Pediatr 2011; 48:37.</a></li><li><a class="nounderline abstract_t">Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 1999; 116:1464.</a></li><li><a class="nounderline abstract_t">Das SK, Faruque AS, Chisti MJ, et al. Changing trend of persistent diarrhoea in young children over two decades: observations from a large diarrhoeal disease hospital in Bangladesh. Acta Paediatr 2012; 101:e452.</a></li><li><a class="nounderline abstract_t">Fischer Walker CL, Friberg IK, Binkin N, et al. Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis. PLoS Med 2011; 8:e1000428.</a></li><li><a class="nounderline abstract_t">Ochoa TJ, Salazar-Lindo E, Cleary TG. Management of children with infection-associated persistent diarrhea. Semin Pediatr Infect Dis 2004; 15:229.</a></li><li><a class="nounderline abstract_t">Black RE. Persistent diarrhea in children of developing countries. Pediatr Infect Dis J 1993; 12:751.</a></li><li><a class="nounderline abstract_t">Claeson M, Merson MH. Global progress in the control of diarrheal diseases. Pediatr Infect Dis J 1990; 9:345.</a></li><li><a class="nounderline abstract_t">Schiller LR. Chronic diarrhea. Gastroenterology 2004; 127:287.</a></li><li><a class="nounderline abstract_t">Islam D, Bandholtz L, Nilsson J, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001; 7:180.</a></li><li><a class="nounderline abstract_t">Klish WJ, Udall JN, Rodriguez JT, et al. Intestinal surface area in infants with acquired monosaccharide intolerance. J Pediatr 1978; 92:566.</a></li><li><a class="nounderline abstract_t">Klish WJ, Udall JN, Calvin RT, Nichols BL. The effect of intestinal solute load on water secretion in infants with acquired monosaccharide intolerance. Pediatr Res 1980; 14:1343.</a></li><li><a class="nounderline abstract_t">Karim AS, Akhter S, Rahman MA, Nazir MF. Risk factors of persistent diarrhea in children below five years of age. Indian J Gastroenterol 2001; 20:59.</a></li><li><a class="nounderline abstract_t">Bhandari N, Bhan MK, Sazawal S, et al. Association of antecedent malnutrition with persistent diarrhoea: a case-control study. BMJ 1989; 298:1284.</a></li><li><a class="nounderline abstract_t">Manger MS, Taneja S, Strand TA, et al. Poor folate status predicts persistent diarrhea in 6- to 30-month-old north Indian children. J Nutr 2011; 141:2226.</a></li><li><a class="nounderline abstract_t">Mondal D, Minak J, Alam M, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2012; 54:185.</a></li><li><a class="nounderline abstract_t">Syed S, Ali A, Duggan C. Environmental Enteric Dysfunction in Children. J Pediatr Gastroenterol Nutr 2016; 63:6.</a></li><li><a class="nounderline abstract_t">Owino V, Ahmed T, Freemark M, et al. Environmental Enteric Dysfunction and Growth Failure/Stunting in Global Child Health. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Sullivan PB, Marsh MN. Small intestinal mucosal histology in the syndrome of persistent diarrhoea and malnutrition: a review. Acta Paediatr Suppl 1992; 381:72.</a></li><li><a class="nounderline abstract_t">Schneider RE, Viteri FE. Morphological aspects of the duodenojejunal mucosa in protein--calorie malnourished children and during recovery. Am J Clin Nutr 1972; 25:1092.</a></li><li><a class="nounderline abstract_t">Chen RY, Kung VL, Das S, et al. Linking the duodenal microbiota to stunting in a cohort of undernourished Bangladeshi children with enteropathy. N Engl J Med 2020; 383:321.</a></li><li><a class="nounderline abstract_t">Amadi B, Zyambo K, Chandwe K, et al. Adaptation of the small intestine to microbial enteropathogens in Zambian children with stunting. Nat Microbiol 2021; 6:445.</a></li><li><a class="nounderline abstract_t">Haberman Y, Iqbal NT, Ghandikota S, et al. Mucosal Genomics Implicate Lymphocyte Activation and Lipid Metabolism in Refractory Environmental Enteric Dysfunction. Gastroenterology 2021; 160:2055.</a></li><li><a class="nounderline abstract_t">Penny ME, Paredes P, Brown KH, et al. Lack of a role of the duodenal microflora in pathogenesis of persistent diarrhea and diarrhea-related malabsorption in Peruvian children. Pediatr Infect Dis J 1990; 9:479.</a></li><li><a class="nounderline abstract_t">Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008; 43:1030.</a></li><li><a class="nounderline abstract_t">Chen RY, Mostafa I, Hibberd MC, et al. A Microbiota-Directed Food Intervention for Undernourished Children. N Engl J Med 2021; 384:1517.</a></li><li><a class="nounderline abstract_t">Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339:548.</a></li><li><a class="nounderline abstract_t">Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhoea in children in low and middle income countries: systematic review. BMC Infect Dis 2009; 9:88.</a></li><li><a class="nounderline abstract_t">Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg 2008; 102:852.</a></li><li><a class="nounderline abstract_t">Becker SL, Vogt J, Knopp S, et al. Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis 2013; 13:37.</a></li><li><a class="nounderline abstract_t">Ngan PK, Khanh NG, Tuong CV, et al. Persistent diarrhea in Vietnamese children: a preliminary report. Acta Paediatr 1992; 81 Suppl 381:124.</a></li><li><a class="nounderline abstract_t">Fagundes-Neto U, Scaletsky IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J 2000; 118:21.</a></li><li><a class="nounderline abstract_t">Ahmed F, Ansaruzzaman M, Haque E, et al. Epidemiology of postshigellosis persistent diarrhea in young children. Pediatr Infect Dis J 2001; 20:525.</a></li><li><a class="nounderline abstract_t">Liu J, Platts-Mills JA, Juma J, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 2016; 388:1291.</a></li><li><a class="nounderline abstract_t">Schilling KA, Omore R, Derado G, et al. Factors Associated with the Duration of Moderate-to-Severe Diarrhea among Children in Rural Western Kenya Enrolled in the Global Enteric Multicenter Study, 2008-2012. Am J Trop Med Hyg 2017; 97:248.</a></li><li><a class="nounderline abstract_t">Baqui AH, Sack RB, Black RE, et al. Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age. J Infect Dis 1992; 166:792.</a></li><li><a class="nounderline abstract_t">Lanata CF, Black RE, Maúrtua D, et al. Etiologic agents in acute vs persistent diarrhea in children under three years of age in peri-urban Lima, Perú. Acta Paediatr Suppl 1992; 381:32.</a></li><li><a class="nounderline abstract_t">Ramakrishna BS, Venkataraman S, Mukhopadhya A. Tropical malabsorption. Postgrad Med J 2006; 82:779.</a></li><li><a class="nounderline abstract_t">Khoshoo V, Bhan MK, Jayashree S, et al. Rotavirus infection and persistent diarrhoea in young children. Lancet 1990; 336:1314.</a></li><li><a class="nounderline abstract_t">Shimizu M, Ohta K, Wada H, et al. Cytomegalovirus-associated protracted diarrhoea in an immunocompetent boy. J Paediatr Child Health 2006; 42:259.</a></li><li><a class="nounderline abstract_t">Sood M, Booth IW. Is prolonged rotavirus infection a common cause of protracted diarrhoea? Arch Dis Child 1999; 80:309.</a></li><li><a class="nounderline abstract_t">Guarino A, Guandalini S, Albano F, et al. Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. Pediatr Infect Dis J 1991; 10:612.</a></li><li><a class="nounderline abstract_t">Unicomb LE, Banu NN, Azim T, et al. Astrovirus infection in association with acute, persistent and nosocomial diarrhea in Bangladesh. Pediatr Infect Dis J 1998; 17:611.</a></li><li><a class="nounderline abstract_t">Koopmans MP, Goosen ES, Lima AA, et al. Association of torovirus with acute and persistent diarrhea in children. Pediatr Infect Dis J 1997; 16:504.</a></li><li><a class="nounderline abstract_t">Feachem RG, Koblinsky MA. Interventions for the control of diarrhoeal diseases among young children: measles immunization. Bull World Health Organ 1983; 61:641.</a></li><li><a class="nounderline abstract_t">Amadi B, Kelly P, Mwiya M, et al. Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition. J Pediatr Gastroenterol Nutr 2001; 32:550.</a></li><li><a class="nounderline abstract_t">Thomas PD, Pollok RC, Gazzard BG. Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome. HIV Med 1999; 1:19.</a></li><li><a class="nounderline abstract_t">Flores J, Okhuysen PC. Genetics of susceptibility to infection with enteric pathogens. Curr Opin Infect Dis 2009; 22:471.</a></li><li><a class="nounderline abstract_t">Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 2005; 115:1119.</a></li><li><a class="nounderline abstract_t">Usha N, Sankaranarayanan A, Walia BN, Ganguly NK. Assessment of preclinical vitamin A deficiency in children with persistent diarrhea. J Pediatr Gastroenterol Nutr 1991; 13:168.</a></li><li><a class="nounderline abstract_t">Bhan MK, Bhandari N. The role of zinc and vitamin A in persistent diarrhea among infants and young children. J Pediatr Gastroenterol Nutr 1998; 26:446.</a></li><li><a class="nounderline abstract_t">Rahman MM, Vermund SH, Wahed MA, et al. Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial. BMJ 2001; 323:314.</a></li><li><a class="nounderline abstract_t">Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2012; :CD005436.</a></li><li class="breakAll">MOST Project. WHO/CAH Diarrhoea treatment guidelines including new recommendations for the use of ORS and zinc supplementation for clinic-based healthcare workers. 2005. Available at: http://www.mostproject.org/ (Accessed on January 08, 2008).</li><li><a class="nounderline abstract_t">Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000; 72:1516.</a></li><li><a class="nounderline abstract_t">Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 2008; 121:326.</a></li><li><a class="nounderline abstract_t">Feachem RG, Koblinsky MA. Interventions for the control of diarrhoeal diseases among young children: promotion of breast-feeding. Bull World Health Organ 1984; 62:271.</a></li><li><a class="nounderline abstract_t">Sazawal S, Bhan MK, Bhandari N. Type of milk feeding during acute diarrhoea and the risk of persistent diarrhoea: a case control study. Acta Paediatr Suppl 1992; 381:93.</a></li><li><a class="nounderline abstract_t">Tovo PA, de Martino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet 1992; 339:1249.</a></li><li><a class="nounderline abstract_t">Guarino A, Tarallo L, Guandalini S, et al. Impaired intestinal function in symptomatic HIV infection. J Pediatr Gastroenterol Nutr 1991; 12:453.</a></li><li><a class="nounderline abstract_t">Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease. J Pediatr Gastroenterol Nutr 1996; 22:359.</a></li><li><a class="nounderline abstract_t">Canani RB, Cirillo P, Mallardo G, et al. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology 2003; 124:368.</a></li><li><a class="nounderline abstract_t">Feasey NA, Healey P, Gordon MA. Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 2011; 34:587.</a></li><li><a class="nounderline abstract_t">Huilan S, Zhen LG, Mathan MM, et al. Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 1991; 69:549.</a></li><li class="breakAll">WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years (published 7/6/23). Available at: https://app.magicapp.org/#/guideline/noPQkE (Accessed on August 24, 2023).</li><li><a class="nounderline abstract_t">Guarino A, Albano F, Working Group on Intestinal Infections of the Italian Society of Paediatric Gastroenterology and Hepatology. Guidelines for the approach to outpatient children with acute diarrhoea. Acta Paediatr 2001; 90:1087.</a></li><li class="breakAll">World Health Organization. Expert Consultation on Oral Rehydration Salts (ORS) Formulation. 2014. Available at: http://rehydrate.org/ors/expert-consultation.html (Accessed on May 25, 2016).</li><li><a class="nounderline abstract_t">Houston KA, Gibb JG, Maitland K. Oral rehydration of malnourished children with diarrhoea and dehydration: A systematic review. Wellcome Open Res 2017; 2:66.</a></li><li class="breakAll">Médecins Sans Frontières. ReSoMal (REhydration SOlution for MALnutrition) oral. 2022. Available at: https://medicalguidelines.msf.org/en/viewport/EssDr/english/resomal-rehydration-solution-for-malnutrition-oral-16684569.html#section-target-6 (Accessed on January 27, 2023).</li><li><a class="nounderline abstract_t">Evaluation of an algorithm for the treatment of persistent diarrhoea: a multicentre study. International Working Group on Persistent Diarrhoea. Bull World Health Organ 1996; 74:479.</a></li><li><a class="nounderline abstract_t">de Mattos AP, Ribeiro TC, Mendes PS, et al. Comparison of yogurt, soybean, casein, and amino acid-based diets in children with persistent diarrhea. Nutr Res 2009; 29:462.</a></li><li><a class="nounderline abstract_t">Gunasekaran D, Chandramohan A, Karthikeyan K, et al. Effect of Green Banana (Musa paradisiaca) on Recovery in Children With Acute Watery Diarrhea With No Dehydration : A Randomized Controlled Trial. Indian Pediatr 2020; 57:1114.</a></li><li><a class="nounderline abstract_t">Islam K, Konar MC, Roy A, et al. Role of cooked green banana in home management of acute diarrhea in under-5 children. J Trop Pediatr 2022; 69.</a></li><li><a class="nounderline abstract_t">Bhan MK, Bhandari N, Bahl R. Management of the severely malnourished child: perspective from developing countries. BMJ 2003; 326:146.</a></li><li class="breakAll">World Health Organization. WHO/UNICEF Joint statement: Clinical management of acute diarrhea. 2004. Available at: http://www.emro.who.int/cah/pdf/who_unicef_statement.pdf (Accessed on October 19, 2010).</li><li><a class="nounderline abstract_t">Bhutta ZA, Black RE, Brown KH, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999; 135:689.</a></li><li><a class="nounderline abstract_t">Dhingra U, Kisenge R, Sudfeld CR, et al. Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial. N Engl J Med 2020; 383:1231.</a></li><li class="breakAll">World Health Organization. World Health Organization model list of essential medicines for children: 7th list 2019. Available at: https://apps.who.int/iris/handle/10665/325772 (Accessed on August 29, 2019).</li><li class="breakAll">World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. 2005. Available at: http://www.who.int/child_adolescent_health/documents/9241593180/en/index.html (Accessed on November 18, 2009).</li><li><a class="nounderline abstract_t">Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000; 14:65.</a></li><li class="breakAll">World Health Organization. The management of bloody diarrhea in young children. WHO/CDD/94.49. Geneva: World Health Organization, 1994.</li><li><a class="nounderline abstract_t">Traa BS, Walker CL, Munos M, Black RE. Antibiotics for the treatment of dysentery in children. Int J Epidemiol 2010; 39 Suppl 1:i70.</a></li><li><a class="nounderline abstract_t">Ahmed FU, Karim E. Children at risk of developing dehydration from diarrhoea: a case-control study. J Trop Pediatr 2002; 48:259.</a></li><li><a class="nounderline abstract_t">Bhatnagar S, Bhan MK, Singh KD, Shrivastav R. Prognostic factors in hospitalized children with persistent diarrhea: implications for diet therapy. J Pediatr Gastroenterol Nutr 1996; 23:151.</a></li><li><a class="nounderline abstract_t">Bernaola Aponte G, Bada Mancilla CA, Carreazo NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev 2013; :CD007401.</a></li><li><a class="nounderline abstract_t">Grenov B, Namusoke H, Lanyero B, et al. Effect of Probiotics on Diarrhea in Children With Severe Acute Malnutrition: A Randomized Controlled Study in Uganda. J Pediatr Gastroenterol Nutr 2017; 64:396.</a></li><li><a class="nounderline abstract_t">Widodo AD, Timan IS, Bardosono S, et al. Pancreatic exocrine insufficiency in malnourished children and those with persistent diarrhoeae. Asia Pac J Clin Nutr 2016; 25:S57.</a></li><li><a class="nounderline abstract_t">Widodo AD, Setiabudy R, Timan IS, et al. Pancreatic enzyme replacement therapy (PERT) in children with persistent diarrhea: avoidance of elemental diet need, accessibility and costs. Asia Pac J Clin Nutr 2018; 27:512.</a></li></ol></div><div id="topicVersionRevision">Topic 5878 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15184773" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Persistent and chronic diarrhea and malabsorption: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16855263" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Causes of chronic diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17245093" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Chronic enteropathy: clinical aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8904061" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of persistent diarrhoea in children aged 3-36 months at the Kenyatta National Hospital, Nairobi, Kenya.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9849071" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Chronic diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20638937" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1800404" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20566617" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21660370" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Persistent diarrhea: still an important challenge for the pediatrician.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21317467" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Chronic and persistent diarrhea in infants and young children: status statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10348832" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : AGA technical review on the evaluation and management of chronic diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22734659" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Changing trend of persistent diarrhoea in young children over two decades: observations from a large diarrhoeal disease hospital in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21445330" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Scaling up diarrhea prevention and treatment interventions: a Lives Saved Tool analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15494946" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Management of children with infection-associated persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8414804" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Persistent diarrhea in children of developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2191271" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Global progress in the control of diarrheal diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15236193" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Chronic diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11175848" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/633014" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intestinal surface area in infants with acquired monosaccharide intolerance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7208151" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The effect of intestinal solute load on water secretion in infants with acquired monosaccharide intolerance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11305492" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Risk factors of persistent diarrhea in children below five years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2500197" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Association of antecedent malnutrition with persistent diarrhoea: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22013199" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Poor folate status predicts persistent diarrhea in 6- to 30-month-old north Indian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22109945" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26974416" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Environmental Enteric Dysfunction in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940670" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Environmental Enteric Dysfunction and Growth Failure/Stunting in Global Child Health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1421945" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Small intestinal mucosal histology in the syndrome of persistent diarrhoea and malnutrition: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4627874" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Morphological aspects of the duodenojejunal mucosa in protein--calorie malnourished children and during recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32699454" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Linking the duodenal microbiota to stunting in a cohort of undernourished Bangladeshi children with enteropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33589804" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Adaptation of the small intestine to microbial enteropathogens in Zambian children with stunting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33524399" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Mucosal Genomics Implicate Lymphocyte Activation and Lipid Metabolism in Refractory Environmental Enteric Dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2371081" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Lack of a role of the duodenal microflora in pathogenesis of persistent diarrhea and diarrhea-related malabsorption in Peruvian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18609165" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Small intestinal bacterial overgrowth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33826814" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A Microbiota-Directed Food Intervention for Undernourished Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23363771" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Gut microbiomes of Malawian twin pairs discordant for kwashiorkor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19515227" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Pathogens associated with persistent diarrhoea in children in low and middle income countries: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18455741" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : New insights into the epidemiology of enteropathogenic Escherichia coli infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23347408" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12286020" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Persistent diarrhea in Vietnamese children: a preliminary report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10685124" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11368112" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Epidemiology of postshigellosis persistent diarrhea in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27673470" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28719331" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Factors Associated with the Duration of Moderate-to-Severe Diarrhea among Children in Rural Western Kenya Enrolled in the Global Enteric Multicenter Study, 2008-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1527413" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Enteropathogens associated with acute and persistent diarrhea in Bangladeshi children less than 5 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1421938" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Etiologic agents in acute vs persistent diarrhea in children under three years of age in peri-urban Lima, Perú.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17148698" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Tropical malabsorption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1978133" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Rotavirus infection and persistent diarrhoea in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16712555" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Cytomegalovirus-associated protracted diarrhoea in an immunocompetent boy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086932" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Is prolonged rotavirus infection a common cause of protracted diarrhoea?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1909781" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Enteral immunoglobulins for treatment of protracted rotaviral diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9686727" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Astrovirus infection in association with acute, persistent and nosocomial diarrhea in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9154546" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Association of torovirus with acute and persistent diarrhea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6414730" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Interventions for the control of diarrhoeal diseases among young children: measles immunization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11429515" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Intestinal and systemic infection, HIV, and mortality in Zambian children with persistent diarrhea and malnutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11737325" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19633551" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Genetics of susceptibility to infection with enteric pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15940121" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Mechanisms of nutrient modulation of the immune response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1941410" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Assessment of preclinical vitamin A deficiency in children with persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9552143" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The role of zinc and vitamin A in persistent diarrhea among infants and young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11498488" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22696352" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Oral zinc for treating diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22696352" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Oral zinc for treating diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11101480" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18245424" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6610496" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Interventions for the control of diarrhoeal diseases among young children: promotion of breast-feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1421949" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Type of milk feeding during acute diarrhoea and the risk of persistent diarrhoea: a case control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1349667" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1865278" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Impaired intestinal function in symptomatic HIV infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8732898" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Iron deficiency and intestinal malabsorption in HIV disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12557143" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21777262" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1659953" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1659953" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11697412" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Guidelines for the approach to outpatient children with acute diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11697412" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Guidelines for the approach to outpatient children with acute diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29090271" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Oral rehydration of malnourished children with diarrhoea and dehydration: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29090271" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Oral rehydration of malnourished children with diarrhoea and dehydration: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9002328" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Evaluation of an algorithm for the treatment of persistent diarrhoea: a multicentre study. International Working Group on Persistent Diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19700033" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Comparison of yogurt, soybean, casein, and amino acid-based diets in children with persistent diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32893836" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Effect of Green Banana (Musa paradisiaca) on Recovery in Children With Acute Watery Diarrhea With No Dehydration : A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36692306" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Role of cooked green banana in home management of acute diarrhea in under-5 children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12531849" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Management of the severely malnourished child: perspective from developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12531849" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Management of the severely malnourished child: perspective from developing countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10586170" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32966722" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32966722" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32966722" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Lower-Dose Zinc for Childhood Diarrhea - A Randomized, Multicenter Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10717503" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Diarrhoea: a significant worldwide problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10717503" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Diarrhoea: a significant worldwide problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20348130" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Antibiotics for the treatment of dysentery in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12405166" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Children at risk of developing dehydration from diarrhoea: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8856582" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Prognostic factors in hospitalized children with persistent diarrhea: implications for diet therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23963712" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Probiotics for treating persistent diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28079729" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Effect of Probiotics on Diarrhea in Children With Severe Acute Malnutrition: A Randomized Controlled Study in Uganda.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28027633" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Pancreatic exocrine insufficiency in malnourished children and those with persistent diarrhoeae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29737796" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Pancreatic enzyme replacement therapy (PERT) in children with persistent diarrhea: avoidance of elemental diet need, accessibility and costs.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
